Evidence map›Paper›PMID 37159758›Full record

ArticleMedical journal of the Islamic Republic of Iran2022

IRAN National Cancer Control Program (IrNCCP): Goals, Strategies, and Programs.

Ali Motlagh, Elham Ehsani-Chimeh, Maisa Yamrali, Farzaneh Moshiri, Gholamreza Roshandel, Elham Partovipour, Freshteh Salavati, Mostafa Khoshabi, Nadia Tavakoli, Freshteh Asgari and 6 more

Abstract read
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ali MotlaghDepartment of Radiation Oncology, Imam Hossein Hospital, Cancer Research Center, Shahid Beheshti Medical University, Tehran, Iran.
Elham Ehsani-ChimehNational Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-6084-7930
Maisa YamraliCancer Department, Vice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Farzaneh MoshiriCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Gholamreza RoshandelGolestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Elham PartovipourCancer Department, Vice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Freshteh SalavatiCancer Department, Vice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Mostafa KhoshabiDepartment of Geospatial Information System (GIS), Center of Excellence in GIS, K.N. Toosi Uni. of Technology, Tehran, Iran.
Nadia TavakoliDepartment of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Freshteh AsgariCancer Department, Vice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Alireza RaisiDepartment of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza MalekzadehDepartment of Internal Medicine, School of Medicine; Digestive Oncology Research Center; Digestive Diseases Research Institute; Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Alireza Mahdavi HezavehCenter for Non-Communicable Disease Control, Vice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Kamal HeidariVice Chancellery for Health, Iran Ministry of Health and Medical Education, Tehran, Iran.
Koorosh EtemadDepartment of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Afshin OstovarEndocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-8670-5797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Annually, over 131000 new cases of cancer have been identified in Iran, with an increasing trend that is predicted to grow by 40% by 2025. The most important contributing factors to this increase are the improvement of the health service delivery system, increased life expectancy, and the aging of the population. The aim of this study was to develop Iran's "National Cancer Control Program" (IrNCCP). Methods: The present study is a cross-sectional study that was conducted in 2013 using the method of reviewing studies and documents and focused group discussions and a panel of experts. In this study, the available evidence related to cancer status and its care in Iran and other countries, as well as national and international upstream documents, were reviewed and analyzed. Then, by analyzing the current situation in Iran and other countries and conducting stakeholder analysis with the strategic planning approach, the IrNCCP was developed with a 12-year horizon consisting of goals, strategies, programs, and performance indicators. Results: This program has 4 main components, including Prevention, Early Detection, Diagnosis and Treatment, and Supportive and Palliative care, as well as 7 supporting components including Governance and policy-making, Cancer Research, Developing facilities, equipment, and service delivery network, Providing and managing human resources, Providing and managing financial resources, Cancer information system management and registry, and Participation of NGOs, charities, and the private sector. Conclusion: Iran's National Cancer Control Program has been developed comprehensively with cross-sectoral cooperation and stakeholder participation. However, like any long-term health intervention, strengthening its governance structure both in terms of implementation and achievement of expected goals and evaluation and modification during the implementation of the program is essential.

Indexed as

CancerCancer ControlCancer control programCancer PlanningPlanning

Identifiers

PMID37159758
PMCPMC10163209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.